Ultrasonic and Histopathological Evaluation to Exclude Premalignant and Malignant Lesions in Perimenopausal and Postmenopausal Women Presenting as Abnormal Uterine Bleeding
This study evaluated 100 perimenopausal and postmenopausal women with abnormal uterine bleeding, finding 49% benign, 9% premalignant, and 42% malignant conditions, with squamous cell carcinoma being the most frequent malignancy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This prospective study evaluated 100 perimenopausal and postmenopausal women presenting with abnormal uterine bleeding using Pap smear and cervical biopsy, followed by abdominal/pelvic ultrasound, with endometrial biopsy performed when endometrial thickness exceeded age-specific cut-offs (11 mm in perimenopause, 4 mm postmenopause); all specimens were histopathologically examined to identify benign, premalignant, and malignant causes and to characterize endometrial and cervical patterns. Cervical pathology was found in 47% of cases, organic uterine body causes including fibroid/adenomyosis in 26%, thickened endometrium in 24%, and endometrial polyp in 3; overall distributions were 49% benign, 9% premalignant, and 42% malignant, with most malignancies being cervical cancer. Major limitation noted is the higher malignant incidence likely reflecting its setting at a Regional Cancer Centre, which may affect generalizability. Relevance to endometriosis: adenomyosis was included among “organic cause of uterine body” causes of abnormal bleeding in this cohort, though the study’s primary focus was excluding premalignant and malignant lesions rather than endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
7,288 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Materials and methods
Result
Conclusion
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? 2012
- Clinical, histopathological and therapeutic considerations in non-neoplastic abnormal uterine bleeding in menopause transition. 2011
Cited by (1)
References (13)
- Clinical, histopathological and therapeutic considerations in non-neoplastic abnormal uterine bleeding in menopause transition. via openalex
- The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? via openalex
- W2048381313 via openalex
- W2059684247 via openalex
- W2080606659 via openalex
- W2088994034 via openalex
- W2108018874 via openalex
- W2184149971 via openalex
- W2189547320 via openalex
- W2316670708 via openalex
- W223555368 via openalex
- W4285719527 via openalex
- W2030663644 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-14T06:08:20.186862+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:29.487098+00:00